IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $879,899 | +74.6% | 22,920 | -13.7% | 0.01% | +100.0% |
Q2 2023 | $504,071 | +8.1% | 26,572 | -11.6% | 0.01% | 0.0% |
Q1 2023 | $466,401 | -74.5% | 30,071 | -70.8% | 0.01% | -76.2% |
Q4 2022 | $1,827,451 | +258.3% | 102,955 | +12.7% | 0.02% | +250.0% |
Q3 2022 | $510,000 | +54.5% | 91,343 | +7.9% | 0.01% | +50.0% |
Q2 2022 | $330,000 | – | 84,635 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |